IFNG and myasthenia gravis: They demonstrate that depleting the Breg2 population in MG patients did not increase the frequency of IFN-γ- and TNF-α-producing CD4+ T cells, suggesting that the Breg2 subset in MG is defective in suppressing T cell function.